The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro

Laura Papagno(Centre National de la Recherche Scientifique), Francesco Nicoli(University of Ferrara), Victor Appay(Inserm), David A. Price(University Hospital of Wales), Anna Lissina(At Bristol), Nozomi Kuse(Kumamoto University), Emma Gostick(University Hospital of Wales)
Scientific Reports
July 15, 2020
Cited by 13


Related Papers